Myriad Genetics launched an enhanced RiskScore assessment to support more personalized breast cancer screening. The tool uses genetic insights to help providers

Myriad Genetics launched an enhanced RiskScore assessment to support more personalized breast cancer screening. The tool uses genetic insights to help providers tailor screening discussions, with the company emphasizing preventive care and health equity.